Therapeutic approaches to modulating glutathione levels as a pharmacological strategy in Alzheimer's disease

N Braidy, M Zarka, J Welch… - Current Alzheimer …, 2015 - ingentaconnect.com
Accumulating evidence has suggested the involvement of oxidative stress in the
pathogenesis of Alzheimer's disease (AD). The main endogenous antioxidant, glutathione …
被引用次数：44 相关文章

Therapeutic approaches to modulating glutathione levels as a pharmacological strategy in Alzheimer's disease

N Braidy, M Zarka, J Welch… - Current Alzheimer …, 2015 - researchers.mq.edu.au
Accumulating evidence has suggested the involvement of oxidative stress in the
pathogenesis of Alzheimer's disease (AD). The main endogenous antioxidant, glutathione …

Therapeutic approaches to modulating glutathione levels as a pharmacological strategy in Alzheimer's disease

C Peter, N Braidy, M Zarka… - Current Alzheimer …, 2015 - pubmed.ncbi.nlm.nih.gov
Accumulating evidence has suggested the involvement of oxidative stress in the
pathogenesis of Alzheimer's disease (AD). The main endogenous antioxidant, glutathione …

Therapeutic Approaches to Modulating Glutathione Levels as a Pharmacological Strategy in Alzheimer's Disease

N Braidy, M Zarka, J Welch, W Bridge - Current Alzheimer Research, 2015 - hero.epa.gov
Accumulating evidence has suggested the involvement of oxidative stress in the
pathogenesis of Alzheimer's disease (AD). The main endogenous antioxidant, glutathione …

[引用][C] Therapeutic Approaches to Modulating Glutathione Levels as a Pharmacological Strategy in Alzheimer's Disease

N Braidy, M Zarka, J Welch, W Bridge - Current Alzheimer Research, 2015 - cir.nii.ac.jp
Therapeutic Approaches to Modulating Glutathione Levels as a Pharmacological Strategy in
Alzheimer’s Disease | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細 …

Therapeutic Approaches to ModulatingGlutathione Levels as a Pharmacological strategy in Alzheimer's Disease.

N Braidy, M Zarka, J Welch, W Bridge - Current Alzheimer Research, 2015 - europepmc.org
Accumulating evidence has suggested the involvement of oxidative stress in the
pathogenesis of Alzheimer's disease (AD). The main endogenousantioxidant, glutathione …

Therapeutic approaches to modulating glutathione levels as a pharmacological strategy in Alzheimer's disease.

C Peter, N Braidy, M Zarka, J Welch… - Current Alzheimer …, 2015 - europepmc.org
Accumulating evidence has suggested the involvement of oxidative stress in the
pathogenesis of Alzheimer's disease (AD). The main endogenous antioxidant, glutathione …

Therapeutic Approaches to ModulatingGlutathione Levels as a Pharmacological strategy in Alzheimer's Disease

N Braidy, M Zarka, J Welch… - Current Alzheimer … - pubmed.ncbi.nlm.nih.gov
Accumulating evidence has suggested the involvement of oxidative stress in the
pathogenesis of Alzheimer's disease (AD). The main endogenousantioxidant, glutathione …